Sleep apnea drug dose showdown: which works best?
NCT ID NCT04726982
First seen Nov 01, 2025 · Last updated Jun 08, 2026 · Updated 30 times
Summary
This study tested two different doses of acetazolamide, a drug that helps stabilize breathing, in 91 adults with moderate to severe obstructive sleep apnea. The goal was to see which dose better reduces the number of breathing pauses during sleep. Participants took the drug or a placebo for a short time, and their sleep apnea severity was measured before and after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.